ArriVent BioPharma (AVBP) Insider Trading & Ownership $27.07 -0.32 (-1.17%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$27.04 -0.02 (-0.09%) As of 02/21/2025 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ArriVent BioPharma (NASDAQ:AVBP) Insider Buying and Selling ActivityNumber OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$18.00 MNumber OfInsiders Selling(Last 3 Years)0 Get AVBP Insider Trade Alerts Want to know when executives and insiders are buying or selling ArriVent BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AVBP Insider Buying and Selling by Quarter ArriVent BioPharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/30/2024Hillhouse Investment ManagemenMajor ShareholderBuy555,555$18.00$9,999,990.00 1/30/2024Orbimed Advisors LlcDirectorBuy444,444$18.00$7,999,992.00 (Data available from 1/1/2013 forward) AVBP Insider Trading Activity - Frequently Asked Questions Who is on ArriVent BioPharma's Insider Roster? The list of insiders at ArriVent BioPharma includes Hillhouse Investment Managemen, and Orbimed Advisors Llc. Learn more on insiders at AVBP. Which ArriVent BioPharma insiders have been buying company stock? The following insiders have purchased AVBP shares in the last 24 months: Hillhouse Investment Managemen ($9,999,990.00), and Orbimed Advisors Llc ($7,999,992.00). How much insider buying is happening at ArriVent BioPharma? Insiders have purchased a total of 999,999 AVBP shares in the last 24 months for a total of $17,999,982.00 bought. ArriVent BioPharma Key ExecutivesDr. Zhengbin Yao Ph.D. (Age 58)Co-Founder, Chairman, President & CEO Compensation: $791.09kDr. Stuart Lutzker M.D. (Age 63)Ph.D., Co-Founder, President of Research & Development and Director Compensation: $709.43kMs. Robin LaChapelle M.A. (Age 51)Co-Founder & COO Compensation: $586.45kMr. Winston Kung M.B.A. (Age 48)CFO & Treasurer Ms. Yang Wang Ph.D.Chief Technology OfficerMr. James Paul Kastenmayer J.D. (Age 52)Ph.D., General Counsel & Secretary Dr. Dandan Dong (Age 39)Chief Business Officer Ms. Meghna ChowdarySenior Vice President of Commercial Strategy More Insider Trading Tools from MarketBeat Related Companies Arcellx Insider Trading Akero Therapeutics Insider Trading Rhythm Pharmaceuticals Insider Trading Scholar Rock Insider Trading Immunovant Insider Trading Apellis Pharmaceuticals Insider Trading Viking Therapeutics Insider Trading ACADIA Pharmaceuticals Insider Trading Crinetics Pharmaceuticals Insider Trading Zai Lab Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:AVBP) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
